Diagnosis and Prognosis of Pulmonary Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 1775

Special Issue Editors


E-Mail Website
Guest Editor
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy
Interests: immunotherapy; lung cancer; mitochondria; reactive oxygen and nitrogen species; immuno-checkpoint inhibitors

Special Issue Information

Dear Colleagues,

This Special Issue invites original research articles and comprehensive reviews focused on improving the diagnosis and prognostic evaluation of major pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung diseases and lung cancer. The aim of this issue is to highlight novel techniques and innovative methodologies that enhance early detection, disease phenotyping, risk stratification and outcome prediction across the spectrum of respiratory disorders.

We particularly welcome contributions employing advanced imaging, molecular and circulating biomarkers, omics approaches, artificial intelligence, machine learning and integrative clinical models, as well as translational and real-world studies with direct clinical relevance. By bringing together cutting-edge methodological advances and disease-specific applications, this Special Issue seeks to foster precision medicine approaches and improve patient management and prognosis in pulmonary diseases.

Dr. Fabio Perrotta
Prof. Dr. Filippo Scialò
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • interstitial lung disease
  • pulmonology
  • airway obstruction
  • pulmonary medicine
  • respiration disorders

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop